Search

Author/Creator Zwillich, Samuel

1. Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs. Issue 1 (December 2015)

Authors:
Strand, Vibeke; Kremer, Joel; Wallenstein, Gene; Kanik, Keith; Connell, Carol; Gruben, David; Zwillich, Samuel; Fleischmann, Roy
Journal:
Arthritis research & therapy
Issue:
Volume 17:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis. Issue 1 (December 2016)

Authors:
Genovese, Mark; van Vollenhoven, Ronald; Wilkinson, Bethanie; Wang, Lisy; Zwillich, Samuel; Gruben, David; Biswas, Pinaki; Riese, Richard; Takiya, Liza; Jones, Thomas
Journal:
Arthritis research & therapy
Issue:
Volume 18:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study. Issue 1 (December 2016)

Authors:
Yamanaka, Hisashi; Tanaka, Yoshiya; Takeuchi, Tsutomu; Sugiyama, Naonobu; Yuasa, Hirotoshi; Toyoizumi, Shigeyuki; Morishima, Yosuke; Hirose, Tomohiro; Zwillich, Samuel
Journal:
Arthritis research & therapy
Issue:
Volume 18:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗